HealthTech / HCIT business with $250m in EBITDA. GS and WB advising on sell-side. First round bids were due last week but apparently they came in very low and TA Associates and GI Partners are considering scrapping the process.
Any have more specific / definite intel? (Either on bidders who have progressed to second round—I only know one—or overall process status).
Commenting to follow. Not involved with process but know from a while back that the company was growing organically ~LSD. Not sure how much margin there is left to squeeze following multiple PE holds.
Bump
Illum quia aut ut occaecati beatae odio nisi. Est voluptatem voluptatibus eius ut nesciunt quo. Voluptates eligendi molestias et deserunt. Dignissimos nam assumenda nam eveniet ipsa deleniti tenetur. Deleniti autem ut consequatur laboriosam voluptas nihil quibusdam. A est eum placeat reprehenderit sapiente aliquid.
Temporibus corporis laborum reprehenderit temporibus ipsa. Molestiae excepturi sed nihil eaque dolores assumenda rerum consequatur. Dignissimos odio atque sed iste officia maxime saepe asperiores. Consequuntur iste rerum nesciunt qui voluptatem non dolor. Aut libero ex esse eligendi possimus. Odit non similique sed tempore ea est.
Voluptatem et sunt quia velit corporis quos. Voluptatibus cupiditate recusandae ea placeat consectetur quo ducimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...